TriSalus Life Sciences, Inc. TLSI Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s investing cash flow?
- TriSalus Life Sciences, Inc. (TLSI) reported investing cash flow of -$141K in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s investing cash flow changed year-over-year?
- TriSalus Life Sciences, Inc.'s investing cash flow increased by 80.3% year-over-year, from -$714K to -$141K.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s investing cash flow?
- Over 3 years (2021 to 2024), TriSalus Life Sciences, Inc.'s investing cash flow has grown at a 79.2% compound annual growth rate (CAGR), from $60K to -$345K.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.